Literature DB >> 1656540

Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.

C Waeber1, M Rigo, G Chinaglia, A Probst, J M Palacios.   

Abstract

The density of [125I]iodo-cyanopindolol binding to beta-1 and beta-2 adrenergic receptors was studied in post mortem basal ganglia samples of Huntington's chorea and Parkinson's disease patients using autoradiography. Whereas no significant changes were observed in sections from Parkinson's and Huntington's chorea grade 2 patients, a nearly complete loss of beta-1 binding sites was observed in the basal ganglia of Huntington patients at later stages of the disease. The concentration of beta-2 receptors was increased by a factor 2 in the posterior putamen of all choreic cases. These results are consistent with the view that beta-1 receptors are predominantly located on a subpopulation of neurons which degenerate at late stages of Huntington's chorea, while beta-2 receptors are present mainly on glial elements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656540     DOI: 10.1002/syn.890080405

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

1.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

2.  Astrocytic β2-adrenergic receptors mediate hippocampal long-term memory consolidation.

Authors:  Virginia Gao; Akinobu Suzuki; Pierre J Magistretti; Sylvain Lengacher; Gabriella Pollonini; Michael Q Steinman; Cristina M Alberini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-08       Impact factor: 11.205

3.  Acupuncture Prevents the Impairment of Hippocampal LTP Through β1-AR in Vascular Dementia Rats.

Authors:  Ling-Yong Xiao; Xue-Rui Wang; Jing-Wen Yang; Yang Ye; Wen Zhu; Yan Cao; Si-Ming Ma; Cun-Zhi Liu
Journal:  Mol Neurobiol       Date:  2018-02-13       Impact factor: 5.590

4.  Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.

Authors:  Nirmal Bhide; David Lindenbach; Christopher J Barnum; Jessica A George; Margaret A Surrena; Christopher Bishop
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

Review 5.  Beta2-Adrenoceptor Agonists in Parkinson's Disease and Other Synucleinopathies.

Authors:  Luca Magistrelli; Cristoforo Comi
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-07       Impact factor: 4.147

6.  Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Authors:  Christopher J Barnum; Nirmal Bhide; David Lindenbach; Margaret A Surrena; Adam A Goldenberg; Stefanie Tignor; Anna Klioueva; Hannah Walters; Christopher Bishop
Journal:  Pharmacol Biochem Behav       Date:  2011-09-25       Impact factor: 3.533

7.  Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

Authors:  David Lindenbach; Corinne Y Ostock; Karen L Eskow Jaunarajs; Kristin B Dupre; Christopher J Barnum; Nirmal Bhide; Christopher Bishop
Journal:  J Pharmacol Exp Ther       Date:  2011-03-14       Impact factor: 4.030

8.  Adrenergic receptors in the cerebellum of olivopontocerebellar atrophy.

Authors:  B Grijalba; J Berciano; B Anciones; A Pazos; J Pascual
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 9.  Astrocyte glycogen and lactate: New insights into learning and memory mechanisms.

Authors:  Cristina M Alberini; Emmanuel Cruz; Giannina Descalzi; Benjamin Bessières; Virginia Gao
Journal:  Glia       Date:  2017-10-27       Impact factor: 7.452

10.  Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway.

Authors:  A Pisani; P Bonsi; D Centonze; A Martorana; F Fusco; G Sancesario; C De Persis; G Bernardi; P Calabresi
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.